Miller Richard A MD
Corvus Pharmaceuticals, Inc. · President and CEO
Miller Richard A MD is listed in filings as President and CEO at Corvus Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 20, 2026, including purchase activity. Recent filings connect the profile to Corvus Pharmaceuticals, Inc. (CRVS). The current snapshot covers public activity from Dec 23, 2024 to May 20, 2026. Reported amounts are shown as $60.3K to $8.8M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $60k5k shares | BuyMay 18, 2026 | $12.05 | $14.27 | |
| $23k1.9k shares | BuyMay 18, 2026 | $12.01 | $14.27 |